Genome British Columbia Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 2

Professionals
  • Investments
  • 21

  • Portfolio
  • 14

  • Exits
  • 5

Exits

Genome British Columbia General Information

Description

Founded in 2000, Genome British Columbia is a not-for-profit venture capital firm based in Vancouver, Canada. The firm seeks investments in early stage companies. The firm prefers to make investments in research, entrepreneurship, life sciences, health, forestry, fisheries, aquaculture, agri-food, energy, mining and environmental sectors.

Contact Information

Website
www.genomebc.ca
Year Founded
2000
Investor Status
Actively Seeking New Investments
Primary Investor Type
Not-For-Profit Venture Capital
Primary Office
  • Suite 400-575
  • West 8th Avenue
  • Vancouver, British Columbia V5Z 0C4
  • Canada
+1 (604) 000-0000

Genome British Columbia Investments (21)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
ABOzymes Biomedical 31-Mar-2022 Grant 00000 Biotechnology Pre-Clinical Trials
000000000000 15-Mar-2022 00000 00000 00.000 Therapeutic Devices Generating Revenue 0000 000000 00.0
00000 01-Jun-2021 00000 00000 00000 Therapeutic Devices Generating Revenue 000 00000
0000000 30-Jun-2020 0000 00000 Outcome Management (Healthcare) Generating Revenue
000000000000 00000 02-Jun-2020 00000 00000 00000 Diagnostic Equipment Bankruptcy: Liquidation
00000 0000000 28-May-2020 0000 00000 00.00 Diagnostic Equipment Generating Revenue 0000 000000 00.0
0000000000 16-Apr-2020 00000 00000 Business/Productivity Software Generating Revenue
00000 000000000000 30-Sep-2019 00000 00000 000 Electronics (B2C) Generating Revenue
LightIntegra Technology (Diagnostic Equipment) 24-Apr-2019 Later Stage VC 00.00 Diagnostic Equipment Bankruptcy: Liquidation
Microbiome Insights 09-Apr-2018 Early Stage VC 00.00 Laboratory Services (Healthcare) Generating Revenue
You’re viewing 10 of 21 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Genome British Columbia Exits (5)

Company Name Exit Date Exit Type Exit Size
LightIntegra Technology (Diagnostic Equipment) 01-Nov-2021 Bankruptcy: Liquidation
0000000 14-Oct-2021 000000000000000000 00.00
000000000 00000000 01-Jun-2021 000000000000000000
Cyon Therapuetics 01-May-2019 Out of Business
Anandia 14-Aug-2018 Merger/Acquisition 000.00
To view Genome British Columbia’s complete exits history, request access »

Genome British Columbia Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Genome British Columbia Team (10)

Name Title Deals Funds Boards Office
Pascal Spothelfer Chief Executive Officer & President 0 Vancouver, Canada
Tony Brooks Ph.D Senior Executive, Chief Financial Officer & Vice President, Entrepreneurship & Commercialization 0 0 Vancouver, Canada
Federica Palma Ph.D Chief Scientific Officer & Vice President of Sectors Vancouver, Canada
Pat Brady Director, Industry Innovation Programs 0 0 Vancouver, Canada
Jessica Lu Planning & Evaluation Manager Vancouver, Canada
You’re viewing 5 of 10 team members. Get the full list »

Genome British Columbia Co-Investors (23)

Name With Exits Lead Partner Series Industry
Boardwalk 1 0 Series chart Industry bar
NorthSpring Capital Partners 0 0 Series chart Industry bar
Phoenix Venture Partners 0 0 Series chart Industry bar
Small World Group 0 0 Series chart Industry bar
UBC Seed Fund 0 0 Series chart Industry bar
You’re viewing 5 of 23 co-investors. Get the full list »